Marsh & McLennan Companies (NYSE:MRSH – Free Report) had its price target reduced by Morgan Stanley from $180.00 to $175.00 in a research note published on Monday,Benzinga reports. They currently have an equal weight rating on the financial services provider’s stock.
Other analysts have also recently issued reports about the stock. Piper Sandler lowered their target price on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 26th. UBS Group decreased their price objective on Marsh & McLennan Companies from $230.00 to $203.00 and set a “buy” rating on the stock in a report on Tuesday, June 9th. Barclays dropped their target price on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a report on Wednesday, April 8th. Citigroup raised Marsh & McLennan Companies from a “neutral” rating to a “buy” rating and set a $200.00 price target for the company in a research report on Wednesday, May 6th. Finally, Weiss Ratings cut shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $199.25.
Check Out Our Latest Stock Report on Marsh & McLennan Companies
Marsh & McLennan Companies Stock Up 2.1%
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last announced its quarterly earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating the consensus estimate of $3.21 by $0.08. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. The business had revenue of $7.30 billion for the quarter. The firm’s revenue for the quarter was up 7.6% on a year-over-year basis. As a group, sell-side analysts forecast that Marsh & McLennan Companies will post 10.38 earnings per share for the current fiscal year.
Insider Buying and Selling
In related news, CEO John Q. Doyle sold 16,656 shares of the stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the sale, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $18,889,506.81. This represents a 12.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.38% of the company’s stock.
Institutional Investors Weigh In On Marsh & McLennan Companies
Large investors have recently added to or reduced their stakes in the stock. Solstein Capital LLC bought a new position in Marsh & McLennan Companies in the fourth quarter worth approximately $25,000. Asset Dedication LLC purchased a new position in Marsh & McLennan Companies during the 1st quarter valued at about $25,000. SHP Wealth Management bought a new position in shares of Marsh & McLennan Companies during the fourth quarter valued at approximately $26,000. KERR FINANCIAL PLANNING Corp purchased a new position in shares of Marsh & McLennan Companies in the 4th quarter valued at $27,000. Finally, Golden State Wealth Management LLC purchased a new position in Marsh & McLennan Companies in the fourth quarter valued at about $27,000. 87.99% of the stock is owned by hedge funds and other institutional investors.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Read More
- Five stocks we like better than Marsh & McLennan Companies
- GE Vernova’s Power Surge Turns the Grid Into an AI Trade
- Orbiting Capital: Lawmakers Buy SpaceX Ahead of Index Inclusion
- Big Beautiful Boycott: Can It Really Hurt Coca-Cola, Amazon, and Kraft Heinz Stocks?
- 3 Stocks With Solid Yields and Sustainabale Payouts Boost Dividends Once Again
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
